Bristol-Myers Squibb

Nektar shows durability of Opdivo combo in 18-month update
Fierce Biotech
Mon, 11/11/19 - 10:53 am
Nektar Therapeutics
NKTR-214
Opdivo
Bristol-Myers Squibb
melanoma
clinical trials
Celgene's last hurrah at ASH a defining moment for Bristol-Myers' buyout
Biopharma Dive
Sun, 11/10/19 - 07:56 pm
ASH
Celgene
M&A
Bristol-Myers Squibb
liso-cel
Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?
Motley Fool
Mon, 11/4/19 - 10:23 am
Merck
Bristol-Myers Squibb
Yervoy
Opdivo
Keytruda
lung cancer
Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line
Motley Fool
Thu, 10/31/19 - 11:57 pm
Bristol-Myers Squibb
earnings
Bristol-Myers warns I-O blockbuster Opdivo will be 'under pressure' in 2020
Fierce Pharma
Thu, 10/31/19 - 11:52 pm
Bristol-Myers Squibb
Opdivo
Keytruda
Merck
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Bristol-Myers makes Opdivo pitch for frontline lung cancer with open label PhIII study
Endpoints
Tue, 10/22/19 - 10:39 am
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
advanced non-small cell lung cancer
clinical trials
Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation
Yahoo/Businesswire
Sun, 10/20/19 - 05:27 pm
Bristol-Myers Squibb
Celgene
M&A
A change of the guard for the world’s biggest cancer companies
EP Vantage
Fri, 10/18/19 - 10:16 am
cancer
Bristol-Myers Squibb
Celgene
M&A
Roche
AstraZeneca
Big Pharma giving more money to patient advocacy groups
Beckers Hospital Review
Wed, 10/9/19 - 11:15 pm
Big Pharma
JNJ
AbbVie
Bristol-Myers Squibb
Pfizer
Merck
AstraZeneca
patient advocacy groups
3 Drug Stocks Poised for Gains After Cancer Conference
Investopedia
Sun, 10/6/19 - 12:26 pm
ESMO
cancer
Amgen
Incyte
Bristol-Myers Squibb
Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report
Fierce Pharma
Fri, 10/4/19 - 12:44 pm
Merck
Keytruda
Bristol-Myers Squibb
Pfizer
Eliquis
AbbVie
Humira
As Celgene becomes BMS, its I&I lead lands CEO job at Takeda spinoff
Fierce Biotech
Fri, 09/27/19 - 10:08 am
Celgene
Bristol-Myers Squibb
M&A
Terrie Curran
Phathom
This Bristol-Partnered Biotech Stock Just Fumbled On A Cancer Study
Investors Business Daily
Thu, 09/26/19 - 07:39 pm
Bristol-Myers Squibb
Nektar Therapeutics
breast cancer
clinical trials
NKTR-214
Mike Quigley has personal motivation leading oncology at Bristol-Myers Squibb
Bizjournals
Sat, 09/21/19 - 12:35 pm
Mike Quigley
oncology
Bristol-Myers Squibb
Opdivo
Yervoy
cancer immunotherapy
Bristol-Myers' (BMY) Opdivo Falls Flat in Brain Tumor Study
Yahoo/Zacks.com
Sat, 09/7/19 - 06:18 pm
Bristol-Myers Squibb
Opdivo
glioblastoma
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
Motley Fool
Sat, 09/7/19 - 06:16 pm
FTC
Amgen
Celgene
Bristol-Myers Squibb
M&A
Otezla
Bristol-Myers CEO Giovanni Caforio Named PhRMA Board Chairman
Xtalks
Thu, 09/5/19 - 08:28 pm
PhRMA
Giovanni Caforio
Bristol-Myers Squibb
Pharma CEOs
With third pharma deal, IFM's unorthodox approach paying off
Biopharma Dive
Thu, 09/5/19 - 08:22 pm
IFM Therapeutics
Novartis
Bristol-Myers Squibb
Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint
Endpoints
Thu, 09/5/19 - 10:13 am
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials

Pages